Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ribosomal protein L18 pseudogene (ENSG00000262636) is a non-functional genomic sequence related to the MRPL18 gene. MRPL18 encodes a protein component of the 39S large subunit of the mitochondrial ribosome, involved in protein synthesis within mitochondria[1][5]. However, **pseudogenes such as ENSG00000262636 do not produce a functional protein product**, resulting from historical gene duplications or retrotranspositions and subsequently acquiring disabling mutations[2][3][7]. While the parent gene is essential for mitochondrial translation, pseudogenes are generally considered “genomic fossils” with no direct biological or clinical activity[2][7][8]. This target does not represent a receptor, enzyme, transporter, or any molecule class of therapeutic interest; **it is an annotation artifact**, and there is no evidence or recognized context in which this specific pseudogene is therapeutically actionable, biologically functional, or clinically relevant[2][7].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L18 pseudogene (null).